Leaflet LEVOMEPROMAZIN ASPIRE 25mg tablets

Product code:
W71817001
Quantity:
1
Indicated for:
schizophrenia; bipolar disorder
Route of administration:
oral
Substance:
levomepromazine (antipsychotic)
ATC
N05AA02 — Nervous system | Antipsychotics | Phenothiazines with aliphatic side-chain

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Hyperglycemia

Hyperglycemia

This medicine may increase blood sugar.

Cardiac risk / QT prolongation / arrhythmias

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Seizure risk

Seizure risk

This medicine may increase the risk of seizures.

Drowsiness / sedation

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Levomepromazine is an antipsychotic medication used to treat schizophrenia and other psychotic disorders. It is also used to alleviate symptoms of severe agitation, anxiety, or insomnia.

This medication belongs to the class of typical antipsychotics and works by blocking dopamine receptors in the brain, which helps reduce psychotic symptoms such as hallucinations and delusions.

Levomepromazine is administered orally or by injection, and the dosage is adjusted based on the severity of symptoms and the patient's response. Side effects may include drowsiness, dizziness, dry mouth, weight gain, or low blood pressure.

Patients should be regularly monitored by their doctor, especially if they have other medical conditions or are taking other medications. Pregnant or breastfeeding women should consult a specialist before using this medication.

General data about LEVOMEPROMAZIN ASPIRE 25mg

Substance:
levomepromazine
Date of latest medicines list:
01-05-2026
Product code:
W71817001
Concentration:
25mg
Pharmaceutical form:
tablets
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
PHARMADOX HEALTHCARE LTD. - MALTA
Holder:
ASPIRE PHARMA (MALTA) LIMITED - MALTA
Number:
16543/2026/01
Shelf life:
2 years

Concentrations available for levomepromazine

  • 100mg
  • 25mg